Cipher Pharmaceuticals Inc. (TSE:CPH) Director Sells C$47,215.00 in Stock March 25, 2025 by InsiderTrades.com Share Cipher Pharmaceuticals Inc. (TSE:CPH - Get Free Report) (NASDAQ:CPHR) Director Harold Morton Wolkin sold 3,500 shares of Cipher Pharmaceuticals stock in a transaction on Monday, March 24th. The shares were sold at an average price of C$13.49, for a total value of C$47,215.00. Cipher Pharmaceuticals Stock Down 3.7 %CPH opened at C$12.65 on Tuesday. Cipher Pharmaceuticals Inc. has a 12 month low of C$7.90 and a 12 month high of C$19.69. The business has a 50-day moving average of C$12.88 and a two-hundred day moving average of C$14.42. The company has a debt-to-equity ratio of 41.22, a current ratio of 2.00 and a quick ratio of 2.67. The stock has a market capitalization of C$227.11 million, a price-to-earnings ratio of 13.97 and a beta of 1.20. Cipher Pharmaceuticals Company Profile (Get Free Report)Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company's geographical segments include Canada and the United States. Featured StoriesFive stocks we like better than Cipher Pharmaceuticals3 Grocery Stocks That Are Proving They Are Still Essential Super Micro Stock: $7.2M Call Options Signal Big Upside PotentialWhen to Sell a Stock for Profit or LossTop 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to WatchWhat Investors Need to Know to Beat the MarketD-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com. Insider Buying or Selling at Cipher Pharmaceuticals? Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Cipher Pharmaceuticals and related companies. More From MarketBeatFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | Sponsored7 Tech Stocks That Still Offer Good Value for 2025Technology stocks continue to outperform most of the other market sectors. And, even though many investors may...MarketBeat“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored7 AI Stocks Under $50 Set to Lead the Second Wave of Innovation If artificial intelligence is going to change every aspect of our lives, why do so many investors dismiss it...MarketBeatAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored7 Stocks to Buy as Esports Goes Mainstream It won't surprise you to hear that video games are big business. This sector has grown beyond home gaming co...MarketBeatElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | Sponsored7 Small-Cap Robinhood Stocks Millennials and Gen Z Are Betting On Robinhood Markets Inc. (NASDAQ: HOOD) is one of the more popular sites for retail investors. In 2024, approx...MarketBeat Free Insider Buying and Selling Newsletter Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report. From Our PartnersFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | Sponsored Most Read This MonthTop 3 Insider Stock Buys in March—Are They Still Good in April?Insider Scoop: 4 Stocks Insiders Are Buying and SellingGrocery Outlet Insider and Institutional Buyers Signal BottomCasey’s General Stores Insider Buys Shares of This Must-Own StockEric Swider Sells 5,000 Shares of Trump Media & Technology Group Corp. (NASDAQ:DJT) StockInsider Selling: Roku, Inc. (NASDAQ:ROKU) CAO Sells $14,649.39 in StockBlackRock TCP Capital Corp. (NASDAQ:TCPC) CEO Acquires $77,400.00 in StockReddit, Inc. (NYSE:RDDT) CAO Sells $1,883,410.65 in StockRecent ArticlesAprea Therapeutics, Inc. (NASDAQ:APRE) CEO Purchases $10,120.00 in StockLaramide Resources Ltd. (TSE:LAM) Director Raffi Babikian Sells 21,000 SharesSemrush Holdings, Inc. (NASDAQ:SEMR) Director Sells $13,277.25 in StockPHX Energy Services Corp. (TSE:PHX) Director Karen David-Green Purchases 1,730 SharesInsider Selling: Black Iron Inc. (TSE:BKI) Insider Sells C$15,975.00 in StockBicycle Therapeutics plc (NASDAQ:BCYC) CEO Sells $17,940.74 in StockTwist Bioscience Co. (NASDAQ:TWST) CEO Sells $19,055.16 in StockPaul L. Alpern Sells 2,878 Shares of Arteris, Inc. (NASDAQ:AIP) Stock